URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


3rd RNAi- Based Therapeutics Summit


Date
Apr 19, 2022 - 08:30 AM - Apr 21, 05:00 PM
Organizer
Hanson Wade
Venue
Embassy Suites by Hilton Boston Logan Airport
Location
207, Porter St

Boston,
MA,
USA,
ZIP: 02128
Phone: +16174554188

Ticket Price: USD 2599.0 - USD 5846.0


Welcome to the 3rd Annual RNAi - Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics

Built with biopharmaceutical industry insights, this in person conference will bring together key opinion leaders to delve deep into the key remaining challenges associated with targeted delivery, translation, CMC and clinical development of targeted siRNA therapeutics for modular, reproducible and effective gene silencing therapies against oncology, CNS, rare diseases and beyond.

With 28 pioneering speakers from large pharma, innovative biotech and KOLs of academia who are ready to discuss the full and comprehensive range of RNAi drugs from discovery to development and beyond, join us in Boston to hear how they address the major challenges facing the industry.

URLs:
Tickets: https://go.evvnt.com/974565-2?pid=1052
Brochure: https://go.evvnt.com/974565-3?pid=1052


Prices:
Drug Developer Pricing - 3 Day Pass (Conference + Workshop Day): USD 4946.0,
Drug Developer Pricing - Conference Only: USD 2999.0,
Academic and Research Institute Pricing - 3 Day Pass (Conference + Workshop Day): USD 4246.0,
Academic and Research Institute Pricing - Conference Only: USD 2599.0,
Standard Pricing - 3 Day Pass (Conference + Workshop Day): USD 5846.0,
Standard Pricing - Conference Only: USD 3599.0



Speaker Details


Julia Alterman, Senior Scientist, Khvorova Lab, University of Massachusetts Medical School, Uli Stilz, VP, Novo Nordisk Bio Innovation Hub, Marie Wikstrom Lindholm, SVP and Head of Molecular Design, Silence Therapeutics, David Evans, CSO, Sirnaomics, Ying Yu, Associate Director, AbbVie, Annabelle Biscans, Associate Principal Scientist, AstraZeneca R and D, Tamar Grossman, Global Head of RNA and Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson and Johnson, Zdravka Medarova, CTO, TransCode Therapeutics, Guy Hermans, CEO, Sapreme Technologies BV, Robert Shaffer, Founder and COO, Vrata Therapeutics, Ioanna Mylonaki, Head of Preclinical R and D, Sixfold Bioscience, Leonora Abdullahu, Research Scientist, Eli Lilly and Company, Josh Born, Research Scientist, Eli Lilly and Company, Zhanna Druzina, Director, Protein Engineering Aro Biotherapeutics, Cynthia Arbeeny, CSO, Mitotherapeutix, Jeske Smink, Head of Drug Substance, Silence Therapeutics, Dal-Hee Min, CTO and Co-Founder, Lemonex Inc. and Professor, Seoul National University, Naresh Badgujar, Associate Principal Scientist, AstraZeneca, Ulf Landmesser, Medical Director, Charite - Universitatsmedizin Berlin, Steve Stice, Co-Founder and CSO, Aruna Bio, Justin Murray, Director Research, Amgen, Michel Khrestchatisky, Research Director, CNRS, Director, Institute for Neurophysiopathology, Co-Founder and Scientific Counsel, Vect-Horus, Peter Goughnour, Director of R and D, Curigin, Thomas Thum, Professor and Institute Director and CSO and Co - Founder, Hannover Medical School and Cardior Pharmaceuticals, Xiaobo Zhong, Professor of Pharmacology and Toxicology, University of Connecticut, Daniel O'Reilly, Post Doctoral Associate, Khvorova Lab RNA Therapeutics Institute, Vignesh N. Hariharan, Post Doctoral Associate, Khvorova Lab RNA Therapeutics Institute, Qi Tang, Post Doctoral Associate, Khvorova Lab RNA Therapeutics Institute

Event Categories
Keywords: conference , pharmaceutical




Comments








Events Calendar

SunMonTueWedThuFriSat
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99